Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,270.00
Bid: 12,270.00
Ask: 12,272.00
Change: -134.00 (-1.08%)
Spread: 2.00 (0.016%)
Open: 12,334.00
High: 12,362.00
Low: 12,250.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK stocks recover on Brexit progress hopes after virus-led pullback

Tue, 22nd Dec 2020 10:10

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Britain's fishing rights offer raises hopes for a deal

* UK economy recovers 16% in Q3, recession risks loom

* AstraZeneca down as asthma drug trial fails

* FTSE 100 up 0.6%, FTSE 250 adds 1.3%
(Updates to market close)

By Medha Singh

Dec 22 (Reuters) - UK stocks bounced on Tuesday as fresh
hopes of a trade deal with the European Union outweighed fears
over a mutated variant of the novel coronavirus that has shut
most of the island country.

The mid-cap FTSE 250, considered a barometer for
Brexit sentiment, added 1.3% as the EU chief negotiator said
both sides were inching towards an agreement on fishing though
the politically sensitive matter remains unresolved.

Banks and industrials and consumer discretionary were the
biggest boost to the domestically focused index.

The blue-chip FTSE 100 closed 0.6% after wiping off
more than half of its gains for December on Monday as UK imposed
tough restrictions and countries around the world shut their
borders to Britain due to worries about the new variant.

"The COVID crisis and Brexit uncertainty look set to hang
over equities for the rest of the calendar year and January
could be a difficult period unless there is progress in getting
the virus under control and clarity on when more people will get
vaccinated," said Russ Mould, investment director at AJ Bell.

Official data showed Britain's economic recovery from its
coronavirus crash was quicker than previously thought in the
third quarter, but new lockdowns are threatening to cause a
another recession.

Drugmaker AstraZeneca Plc slipped 1.5% after its
experimental asthma drug with Amgen Inc failed to meet
the main goal of reducing patients' dependence on steroids in a
late-stage trial.

Irish gas station operator Applegreen Plc rose
2.5% after agreeing to be acquired by a consortium led by B&J
Holdings and Blackstone Infrastructure Partners in a deal that
valued it at around $877.66 million.
(Reporting by Medha Singh and Shivani Kumaresan in Bengaluru;
Editing by Rashmi Aich, Sriraj Kalluvila and Richard Chang)

More News
20 May 2024 08:24

TOP NEWS: AstraZeneca plans to build manufacturing plant in Singapore

(Alliance News) - AstraZeneca PLC on Monday announced plans for a USD1.5 billion manufacturing facility in Singapore to produce antibody drug conjugates, treatments that deliver "highly potent cancer-killing agents".

Read more
20 May 2024 07:47

LONDON BRIEFING: Keywords would back GBP2.0 billion bid as EQT circles

(Alliance News) - London's FTSE 100 is called to open higher at the start of the week, while the pound climbed and gold hit another record high, with investors hopeful the Federal Reserve could soon cut US interest rates.

Read more
20 May 2024 07:22

AstraZeneca announces $1.5bn Singapore manufacturing facility

(Sharecast News) - AstraZeneca announced plans to construct a $1.5bn manufacturing facility in Singapore on Monday, dedicated to the production of antibody drug conjugates (ADCs).

Read more
17 May 2024 22:25

Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial

May 17 (Reuters) - AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's patent rights.

Read more
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.